90 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
21 Not yet recruiting Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: everolimus and letrozole
22 Unknown  Biomarkers in Samples From Patients With Endometrial Cancer
Conditions: Endometrial Cancer;   Hereditary Non-polyposis Colon Cancer
Interventions: Genetic: DNA analysis;   Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Genetic: molecular genetic technique;   Genetic: mutation analysis;   Genetic: polymorphism analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
23 Recruiting Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Conditions: Endometrial Cancer;   Gastrointestinal Complications;   Radiation Toxicity;   Urinary Complications
Intervention: Radiation: 45 Gy/25 fractions
24 Recruiting Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Conditions: Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis;   Other: pharmacological study
25 Unknown  Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With High-risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Pelvic and Para-Aortic Radiation 6MV Photon Beam Energy;   Radiation: High Dose Radiation
26 Not yet recruiting A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
Condition: Endometrial Cancer
Intervention: Drug: BMN 673
27 Recruiting Lymph Node Mapping in Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: sentinel lymph node detection;   Drug: indocyanine green solution;   Drug: isosulfan blue;   Procedure: sentinel lymph node biopsy
28 Recruiting Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: carboplatin and paclitaxel;   Other: observation
29 Recruiting Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Radiation: 3D conformational radiation;   Radiation: IMRT
30 Recruiting Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Conditions: Stage IA Endometrial Carcinoma;   Stage IB Endometrial Carcinoma;   Stage II Endometrial Carcinoma;   Stage IIIA Endometrial Carcinoma;   Stage IIIB Endometrial Carcinoma;   Stage IIIC Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Procedure: lymph node mapping;   Procedure: sentinel lymph node biopsy;   Drug: isosulfan blue;   Drug: indocyanine green solution;   Procedure: therapeutic conventional surgery;   Procedure: lymphadenectomy
31 Recruiting Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Dasatinib
32 Unknown  Comparing Robotics and Laparoscopy With Laparotomy/Open Surgery for Endometrial Cancer
Condition: Cancer of the Endometrium
Intervention:
33 Unknown  Prognostic Biomarkers in Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Genetic: DNA analysis;   Genetic: mutation analysis;   Other: laboratory biomarker analysis
34 Unknown  Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Genetic: gene expression analysis;   Other: laboratory biomarker analysis;   Other: medical chart review;   Other: study of socioeconomic and demographic variables
35 Recruiting Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer
Condition: Stage III-IV or Recurrent Endometrial Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
36 Recruiting Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
Conditions: Hyperplasia;   Endometrial Cancer
Intervention: Device: Levonorgestrel IUD
37 Recruiting Thunderbeat Technology vs Standard Bipolar Electro-surgery in Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: Thunderbeat technology;   Procedure: Standard bipolar electrosurgery
38 Recruiting Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
Condition: Endometrial Cancer
Interventions: Procedure: Intensive/Low-Risk Treatment (IA G1; IA G2);   Procedure: Intensive/High-Risk Treatment (≥ IA G3);   Procedure: Minimalist/Low-Risk Treatment (IA G1; IA G2);   Procedure: Minimalist/High-Risk Treatment (≥ IA G3)
39 Unknown  Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: lymphadenectomy;   Procedure: therapeutic conventional therapy;   Procedure: Positron Emission Tomography/ Computed Tomography;   Radiation: fludeoxyglucose F 18
40 Unknown  Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: single-port laparoscopic surgical staging;   Procedure: Four-port laparoscopic surgical staging

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years